Amended ANDA Triggers Another Detrol Complaint

Law360, New York (September 3, 2008, 12:00 AM EDT) -- Pfizer Inc. has filed a new suit against Impax Laboratories Inc. over Impax's attempts to move into the lucrative market for Detrol LA, after Impax changed an abbreviated new drug application to cover a different dosage strength.

Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB filed the suit on Aug. 29 in the U.S. District Court for the District of New Jersey.

Pfizer also sued Impax over Detrol in the U.S. District Court for the Southern District of New York in March, but...
To view the full article, register now.